Maverick Capital Ltd (Lee Ainslie) - Significant Ownership

Notable people
Lee Ainslie
Signature - Title
/s/ Trevor Wiessmann* - By: Maverick Capital Management, LLC, its General Partner By: Lee S. Ainslie III, Manager
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Maverick Capital Ltd.

Significant Ownership of Maverick Capital Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IVVD Invivyd, Inc. Common Stock, $0.0001 par value per share 8.5% $8.9M 10.2M Maverick Capital, Ltd. Jun 30, 2025
RCKT Rocket Pharmaceuticals, Inc. Common Stock, $0.01 par value per share 7.8% $28M $9.44M 8.36M +50.8% Maverick Capital, Ltd. Jun 30, 2025
BTU Peabody Energy Corporation Common Stock, par value $0.01 per share 6.7% $216M $40M 8.16M +22.7% Maverick Capital, Ltd. Sep 30, 2025
WVE Wave Life Sciences Ltd. $0 Par Value Ordinary Shares 5.4% $50.7M 8.26M Maverick Capital, Ltd. Dec 31, 2024
VRNA Verona Pharma Plc Ordinary Shares, nominal value 0.05 GBP per share 3.8% $1.45B 25M Maverick Capital, Ltd. Dec 31, 2024
GUTS Fractyl Health, Inc. Common Stock, $0.00001 par value per share 3.1% $6.76M 4.25M Maverick Capital, Ltd. Sep 30, 2025
CRIS Curis, Inc. Common Stock, par value $0.01 per share 0.4% $84.5K -$1.08M 49.6K -92.7% Maverick Capital, Ltd. Sep 30, 2025

Schedules 13D/G Reported by Maverick Capital Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.